Periodic Reporting for period 1 - BLACANDI (BLACANDI can improve life quality and cut cost of diagnosing and managing bladder cancer in half)

BLACANDI is based on a successfully concluded small fully randomized blinded clinical study of 500 patients presenting with blood in the urine meeting its end-point of a sensitivity of +90%. The Horizon2020 phase I feasibility study identified no competitors that could match...